Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31

Stock News08-04 18:12

Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SSE: 600276) has disclosed its latest share repurchase progress, revealing that as of July 31, 2026, the company had cumulatively bought back 13.75 million shares through the Shanghai Stock Exchange's centralized bidding system. This represents 0.21% of the company's total share capital.

In July 2026 alone, the company purchased 280,000 shares via the same mechanism, accounting for 0.004% of total shares. The buyback price ranged from a high of RMB 54.05 per share to a low of RMB 53.75 per share, with a total expenditure of approximately RMB 15.09 million (excluding transaction fees).

For the entire buyback program as of July 31, the purchase price has fluctuated between a high of RMB 70.00 per share and a low of RMB 45.30 per share, with total spending reaching approximately RMB 853.08 million (excluding transaction fees).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment